Summary
A 63-year-old female developed unexplained hyperglycemia and glycosuria during administration of a total parenteral nutrition regimen on which she had been stable for several months. Because the patient had no history of diabetes or evidence of an infection, chromium deficiency was considered. Plasma chromium level was 0.1 μg/dl (laboratory reference interval: 1.8–3.8 μg/dl). Fourteen days of supplemental intravenous chromium chloride (200 μg/day) allowed complete withdrawal of exogenous insulin with no further hyperglycemia or glycosuria. Correction of unexplained glucose intolerance following vigorous chromium supplementation indicates that the patient had chromium deficiency. Subsequent plasma chromium levels remained unchanged, possibly reflecting the sensitivity limits of the assay that was used, the uncertainty that exists regarding appropriate reference intervals for this element, and the fact that plasma levels do not always correlate with total body stores. The patient did not manifest peripheral neuropathy, which was present in one of the two previously reported cases, nor encephalopathy, which was reported in the other. We conclude that this patient developed chromium deficiency as a result of inadequate administration of chromium in the parenteral formula (6 μg/day) plus excessive enteric losses, and she presented with glucose intolerance as the only clinical manifestation of the deficiency. Caution should be exercised when interpreting plasma chromium in patients with suspected deficiency.
Similar content being viewed by others
References
Schwarz IK, Mertz W: Chromium (III) and the glucose tolerance factor. Arch Biochem Biophys 85:292–295, 1959
Hambridge KM: Chromium nutrition in man. Am J Clin Nutr 27:505–514, 1974
Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A: Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 30:531–538, 1977
Freund H, Atamian S, Fischer JE: Chromium deficiency during total parenteral nutrition. JAMA 241:496–498, 1979
Anderson RA, Polansky MM, Bryden NA, Roginski EE, Patterson KY, Veillon C, Glinsmann W: Urinary chromium excretion of human subjects: Effects of chromium supplementation and glucose loading. Am J Clin Nutr 36:1184–1193, 1982
Versieck J, Hoste J, Barbie F, Steyaert H, DeRudder J, Michels H: Determination of chromium and cobalt in human serum using neutron activation analysis. Clin Chem 24:303–308, 1978
Stitch SR: Trace elements in human tissue. Biochem J 67:97–103, 1957
Phillips GD, Garnys VP: Trace element balance in adults receiving parenteral nutrition: Preliminary data. J Parentr Enter Nutr 5:11–14, 1981
Anonymous: Guidelines for essential trace element preparations for parenteral use. JAMA 241:2051–2054, 1979
Davis JM, Illner H, Dineen P: Increased chromium uptake in polymorphonuclear leukocytes from burned patients. J Trauma 24:1003–1009, 1984
Wolman SL, Anderson GH, Marliss EB, Jeejeebhoy KN: Zinc in total parenteral nutrition: Requirements and metabolic effects. Gastroenterology 76:458–467, 1979
Author information
Authors and Affiliations
Additional information
At the time of this case report, Dr. Brown was Nutritional Support Pharmacist, North Carolina Memorial Hospital, Chapel Hill, North Carolina 27514.
Rights and permissions
About this article
Cite this article
Brown, R.O., Forloines-Lynn, S., Cross, R.E. et al. Chromium deficiency after long-term total parenteral nutrition. Digest Dis Sci 31, 661–664 (1986). https://doi.org/10.1007/BF01318699
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01318699